Francis R LeBlanc

4PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 31, 2024
Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients.

Francis R LeBlanc, Erin H Breese, Karen C Burns

|Jun 05, 2024
A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome.

Francis R LeBlanc, David D Grier, Kasiani C Myers

|Jun 10, 2019
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.

Stephen E Spurgeon, Kamal Sharma, David F Claxton

|Apr 28, 2018
TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.

Jun Yang, Francis R LeBlanc, Shubha A Dighe

Pageof 1

Frequent Collaborators

2 joint publications

Lauren Pommert

1 joint publications

Stephen E Spurgeon

1 joint publications

Thomas L Olson

1 joint publications

David J Feith